Weight change in the acute treatment of bipolar I disorder: A naturalistic observational study of psychiatric inpatients

Journal of Affective Disorders

Volumn 105, Issue 1-3, 2008, Pages 45-52

  Kim, Byungsu ^a   Kim, Soo Jung ^a   Son, Jung In ^a   Joo, Yeon Ho ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

Acute treatment; Bipolar disorder; Obesity; Weight change

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; HALOPERIDOL; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; VALPROIC ACID;

ADULT; ARTICLE; BIPOLAR I DISORDER; BODY MASS; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; FEMALE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBESITY; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME; WEIGHT CHANGE;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; BIPOLAR DISORDER; BODY MASS INDEX; BODY WEIGHT; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HALOPERIDOL; HOSPITALIZATION; HUMANS; LITHIUM CARBONATE; MALE; OBESITY; RISPERIDONE; SMOKING; VALPROIC ACID;

EID: 36849078782     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2007.04.006     Document Type: Article

References (29)

1. Allison D.B., and Casey D.E. Antipsychotic-induced weight gain: a review of the literature. J. Clin. Psychiatry 62 Suppl 7 (2001) 22-31
2. Barsh G.S., Farooqi I.S., and O'Rahilly S. Genetics of body-weight regulation. Nature 404 (2000) 644-651
3. Cassidy F., Ahearn E., and Carroll B.J. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am. J. Psychiatry 156 (1999) 1417-1420
4. Chue P., and Kovacs C.S. Safety and tolerability of atypical antipsychotics in patients with bipolar disorder: prevalence, monitoring and management. Bipolar Disord. 5 Suppl 2 (2003) 62-79
5. Colditz G.A., Willett W.C., Rotnitzky A., and Manson J.E. Weight gain as a risk factor for clinical diabetes mellitus in women. Ann. Intern. Med. 122 (1995) 481-486
6. Elmslie J.L., Silverstone J.T., Mann J.I., Williams S.M., and Romans S.E. Prevalence of overweight and obesity in bipolar patients. J. Clin. Psychiatry 61 (2000) 179-184
7. Elmslie J.L., Mann J.I., Silverstone J.T., Williams S.M., and Romans S.E. Determinants of overweight and obesity in patients with bipolar disorder. J. Clin. Psychiatry 62 (2001) 486-491 quiz 492-483
8. Fagiolini A., Frank E., Houck P.R., Mallinger A.G., Swartz H.A., Buysse D.J., Ombao H., and Kupfer D.J. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J. Clin. Psychiatry 63 (2002) 528-533
9. Fagiolini A., Kupfer D.J., Houck P.R., Novick D.M., and Frank E. Obesity as a correlate of outcome in patients with bipolar I disorder. Am. J. Psychiatry 160 (2003) 112-117
10. Fagiolini A., Frank E., Scott J.A., Turkin S., and Kupfer D.J. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 7 (2005) 424-430
11. Frye M.A., Ketter T.A., Leverich G.S., Huggins T., Lantz C., Denicoff K.D., and Post R.M. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J. Clin. Psychiatry 61 (2000) 9-15
12. Guille C., Sachs G.S., and Ghaemi S.N. A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J. Clin. Psychiatry 61 (2000) 638-642
13. Hennen J., Perlis R.H., Sachs G., Tohen M., and Baldessarini R.J. Weight gain during treatment of bipolar I patients with olanzapine. J. Clin. Psychiatry 65 (2004) 1679-1687
14. Kanazawa M., Yoshiike N., Osaka T., Numba Y., Zimmet P., and Inoue S. Criteria and classification of obesity in Japan and Asia-Oceania. World Rev. Nutr. Diet 94 (2005) 1-12
15. Kawachi I. Physical and psychological consequences of weight gain. J. Clin. Psychiatry 60 Suppl 21 (1999) 5-9
16. Keck P.E., and McElroy S.L. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J. Clin. Psychiatry 64 (2003) 1426-1435
17. Korean Ministry of Health and Welfare. The Korean National Health and Nutrition Survey 2001 (2002) 178-180
18. Lilliker S.L. Prevalence of diabetes in a manic-depressive population. Compr. Psychiatry 21 (1980) 270-275
19. Lipkovich I., Citrome L., Perlis R., Deberdt W., Houston J.P., Ahl J., and Hardy T. Early predictors of substantial weight gain in bipolar patients treated with olanzapine. J. Clin. Psychopharmacol. 26 (2006) 316-320
20. Lissner L., Odell P.M., D'Agostino R.B., Stokes 3rd J., Kreger B.E., Belanger A.J., and Brownell K.D. Variability of body weight and health outcomes in the Framingham population. N. Engl. J. Med. 324 (1991) 1839-1844
21. McElroy S.L., Frye M.A., Suppes T., Dhavale D., Keck Jr. P.E., Leverich G.S., Altshuler L., Denicoff K.D., Nolen W.A., Kupka R., Grunze H., Walden J., and Post R.M. Correlates of overweight and obesity in 644 patients with bipolar disorder. J. Clin. Psychiatry 63 (2002) 207-213
22. Mokdad A.H., Ford E.S., Bowman B.A., Dietz W.H., Vinicor F., Bales V.S., and Marks J.S. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289 (2003) 76-79
23. Regenold W.T., Thapar R.K., Marano C., Gavirneni S., and Kondapavuluru P.V. Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use. J. Affect. Disord. 70 (2002) 19-26
24. Rimm E.B., Stampfer M.J., Giovannucci E., Ascherio A., Spiegelman D., Colditz G.A., and Willett W.C. Body size and fat distribution as predictors of coronary heart disease among middle-aged and older US men. Am. J. Epidemiol. 141 (1995) 1117-1127
25. Spearing M.K., Post R.M., Leverich G.S., Brandt D., and Nolen W. Modification of the Clinical Global Impressions (CGI) Scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Res. 73 (1997) 159-171
26. Stanton J.M. Weight gain associated with neuroleptic medication: a review. Schizophr. Bull. 21 (1995) 463-472
27. Tohen M., Chengappa K.N., Suppes T., Baker R.W., Zarate C.A., Bowden C.L., Sachs G.S., Kupfer D.J., Ghaemi S.N., Feldman P.D., Risser R.C., Evans A.R., and Calabrese J.R. Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabilizer alone. Br. J. Psychiatry 184 (2004) 337-345
28. Willett W.C., Manson J.E., Stampfer M.J., Colditz G.A., Rosner B., Speizer F.E., and Hennekens C.H. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range. JAMA 273 (1995) 461-465
29. Wyatt S.B., Winters K.P., and Dubbert P.M. Overweight and obesity: prevalence, consequences, and causes of a growing public health problem. Am. J. Med. Sci. 331 (2006) 166-174